These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 36583817)

  • 1. Deubiquitinating enzyme Josephin-2 stabilizes PHGDH to promote a cancer stem cell phenotype in hepatocellular carcinoma.
    Wang Y; Li ZX; Wang JG; Li LH; Shen WL; Dang XW
    Genes Genomics; 2023 Feb; 45(2):215-224. PubMed ID: 36583817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PHGDH arginine methylation by PRMT1 promotes serine synthesis and represents a therapeutic vulnerability in hepatocellular carcinoma.
    Wang K; Luo L; Fu S; Wang M; Wang Z; Dong L; Wu X; Dai L; Peng Y; Shen G; Chen HN; Nice EC; Wei X; Huang C
    Nat Commun; 2023 Feb; 14(1):1011. PubMed ID: 36823188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kinesin family member 15 promotes cancer stem cell phenotype and malignancy via reactive oxygen species imbalance in hepatocellular carcinoma.
    Li Q; Qiu J; Yang H; Sun G; Hu Y; Zhu D; Deng Z; Wang X; Tang J; Jiang R
    Cancer Lett; 2020 Jul; 482():112-125. PubMed ID: 31733289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ZEB1 Transcriptionally Activates PHGDH to Facilitate Carcinogenesis and Progression of HCC.
    Wang H; Lin F; Xu Z; Yu S; Li G; Liao S; Zhao W; Zhang F; Wang J; Wang S; Ouyang C; Zhang C; Xia H; Wu Y; Jiang B; Li Q
    Cell Mol Gastroenterol Hepatol; 2023; 16(4):541-556. PubMed ID: 37331567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphoglycerate dehydrogenase inhibition induces p-mTOR-independent autophagy and promotes multilineage differentiation in embryonal carcinoma stem-like cells.
    Sharif T; Martell E; Dai C; Ghassemi-Rad MS; Lee K; Singh SK; Weaver ICG; Gujar S
    Cell Death Dis; 2018 Sep; 9(10):990. PubMed ID: 30250195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. OTUD5 promotes the growth of hepatocellular carcinoma by deubiquitinating and stabilizing SLC38A1.
    Yang Y; Jia S; Zhu N; Xiao X; Ma Y; Tu K; Guo Y; Xu Q
    Biol Direct; 2024 Apr; 19(1):31. PubMed ID: 38658981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High Phosphoglycerate Dehydrogenase Expression Induces Stemness and Aggressiveness in Thyroid Cancer.
    Jeon MJ; You MH; Han JM; Sim S; Yoo HJ; Lee WK; Kim TY; Song DE; Shong YK; Kim WG; Kim WB
    Thyroid; 2020 Nov; 30(11):1625-1638. PubMed ID: 32438862
    [No Abstract]   [Full Text] [Related]  

  • 8. Glyceraldehyde-3-phosphate dehydrogenase promotes liver tumorigenesis by modulating phosphoglycerate dehydrogenase.
    Liu S; Sun Y; Jiang M; Li Y; Tian Y; Xue W; Ding N; Sun Y; Cheng C; Li J; Miao X; Liu X; Zheng L; Huang K
    Hepatology; 2017 Aug; 66(2):631-645. PubMed ID: 28387968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deubiquitinating enzyme JOSD2 promotes hepatocellular carcinoma progression through interacting with and inhibiting CTNNB1 degradation.
    Huang Y; Zeng J; Liu T; Xu Q; Song X; Zeng J
    Cell Biol Int; 2022 Jul; 46(7):1089-1097. PubMed ID: 35568970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FBXO7 ubiquitinates PRMT1 to suppress serine synthesis and tumor growth in hepatocellular carcinoma.
    Luo L; Wu X; Fan J; Dong L; Wang M; Zeng Y; Li S; Yang W; Jiang J; Wang K
    Nat Commun; 2024 Jun; 15(1):4790. PubMed ID: 38839752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Novel Function for KLF4 in Modulating the De-differentiation of EpCAM
    Karagonlar ZF; Akbari S; Karabicici M; Sahin E; Avci ST; Ersoy N; Ates KE; Balli T; Karacicek B; Kaplan KN; Celiker C; Atabey N; Erdal E
    Cells; 2020 May; 9(5):. PubMed ID: 32408542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phosphoglycerate dehydrogenase promotes pancreatic cancer development by interacting with eIF4A1 and eIF4E.
    Ma X; Li B; Liu J; Fu Y; Luo Y
    J Exp Clin Cancer Res; 2019 Feb; 38(1):66. PubMed ID: 30744688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HOXB7 accelerates the malignant progression of hepatocellular carcinoma by promoting stemness and epithelial-mesenchymal transition.
    Huan HB; Yang DP; Wen XD; Chen XJ; Zhang L; Wu LL; Bie P; Xia F
    J Exp Clin Cancer Res; 2017 Jun; 36(1):86. PubMed ID: 28646927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-589-5p inhibits MAP3K8 and suppresses CD90
    Zhang X; Jiang P; Shuai L; Chen K; Li Z; Zhang Y; Jiang Y; Li X
    J Exp Clin Cancer Res; 2016 Nov; 35(1):176. PubMed ID: 27835990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of ATOH8 Increases Stem Cell Features of Hepatocellular Carcinoma Cells.
    Song Y; Pan G; Chen L; Ma S; Zeng T; Man Chan TH; Li L; Lian Q; Chow R; Cai X; Li Y; Li Y; Liu M; Li Y; Zhu Y; Wong N; Yuan YF; Pei D; Guan XY
    Gastroenterology; 2015 Oct; 149(4):1068-81.e5. PubMed ID: 26099525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The deubiquitinating enzyme USP19 facilitates hepatocellular carcinoma progression through stabilizing YAP.
    Tian Z; Xu C; He W; Lin Z; Zhang W; Tao K; Ding R; Zhang X; Dou K
    Cancer Lett; 2023 Nov; 577():216439. PubMed ID: 37832781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low glucose metabolite 3-phosphoglycerate switches PHGDH from serine synthesis to p53 activation to control cell fate.
    Wu YQ; Zhang CS; Xiong J; Cai DQ; Wang CZ; Wang Y; Liu YH; Wang Y; Li Y; Wu J; Wu J; Lan B; Wang X; Chen S; Cao X; Wei X; Hu HH; Guo H; Yu Y; Ghafoor A; Xie C; Wu Y; Xu Z; Zhang C; Zhu M; Huang X; Sun X; Lin SY; Piao HL; Zhou J; Lin SC
    Cell Res; 2023 Nov; 33(11):835-850. PubMed ID: 37726403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. USP40 promotes hepatocellular carcinoma cell proliferation, migration and stemness by deubiquitinating and stabilizing Claudin1.
    Wu Q; Qiu Y; Guo J; Yuan Z; Yang Y; Zhu Q; Zhang Z; Guo J; Wu Y; Zhang J; Huang D; Tu K; Hu X
    Biol Direct; 2024 Feb; 19(1):13. PubMed ID: 38308285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deubiquitinating enzyme USP46 suppresses the progression of hepatocellular carcinoma by stabilizing MST1.
    Qiu Y; Huang D; Sheng Y; Huang J; Li N; Zhang S; Hong Z; Yin X; Yan J
    Exp Cell Res; 2021 Aug; 405(1):112646. PubMed ID: 34029571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxytetracycline have the therapeutic efficiency in CD133
    Song Y; Kim IK; Choi I; Kim SH; Seo HR
    Sci Rep; 2018 Oct; 8(1):16100. PubMed ID: 30382122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.